BioLife Solutions (BLFS)

BioLife Solutions Stock Analysis & Ratings

BLFS Stock Chart & Stats

Day’s Range$12.09 - $12.81
52-Week Range$10.40 - $60.67
Previous Close$12.42
Average Volume (3M)413.13K
Market Cap$539.88M
P/E Ratio-40.1
Next EarningsAug 11, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score1
EPS (TTM)-0.32



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was BioLife Solutions’s price range in the past 12 months?
BioLife Solutions lowest stock price was $10.40 and its highest was $60.67 in the past 12 months.
    What is BioLife Solutions’s market cap?
    BioLife Solutions’s market cap is $539.88M.
      What is BioLife Solutions’s price target?
      The average price target for BioLife Solutions is $37.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $65.00 ,the lowest forecast is $28.00. The average price target represents 190.65% Increase from the current price of $12.73.
        What do analysts say about BioLife Solutions?
        BioLife Solutions’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
          When is BioLife Solutions’s upcoming earnings report date?
          BioLife Solutions’s upcoming earnings report date is Aug 11, 2022 which is in 86 days.
            How were BioLife Solutions’s earnings last quarter?
            BioLife Solutions released its earnings results on May 09, 2022. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.259 by $0.089.
              Is BioLife Solutions overvalued?
              According to Wall Street analysts BioLife Solutions’s price is currently Undervalued.
                Does BioLife Solutions pay dividends?
                BioLife Solutions does not currently pay dividends.
                What is BioLife Solutions’s EPS estimate?
                BioLife Solutions’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does BioLife Solutions have?
                BioLife Solutions has 42,410,000 shares outstanding.
                  What happened to BioLife Solutions’s price movement after its last earnings report?
                  BioLife Solutions reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.259. Following the earnings report the stock price went up 7.798%.
                    Which hedge fund is a major shareholder of BioLife Solutions?
                    Among the largest hedge funds holding BioLife Solutions’s share is Bridgewater Associates, LP. It holds BioLife Solutions’s shares valued at 1M.


                      BioLife Solutions Stock Analysis

                      Smart Score
                      Price Target
                      ▲(190.65% Upside)
                      Strong Buy
                      The BioLife Solutions stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      BioLife Solutions

                      BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

                      Similar Stocks
                      Price & Change
                      NanoString Tech
                      Thermo Fisher

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis